TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Short Interest Update

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) was the target of a large decline in short interest in November. As of November 30th, there was short interest totalling 157,200 shares, a decline of 48.3% from the November 15th total of 304,300 shares. Based on an average daily volume of 1,350,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 4.0% of the company’s stock are short sold.

TFF Pharmaceuticals Price Performance

Shares of TFF Pharmaceuticals stock remained flat at $0.07 during trading hours on Friday. The firm has a market cap of $288,795.00, a price-to-earnings ratio of -0.01 and a beta of 1.07. The stock has a fifty day moving average of $1.31 and a two-hundred day moving average of $1.73. TFF Pharmaceuticals has a fifty-two week low of $0.06 and a fifty-two week high of $11.00.

Institutional Inflows and Outflows

An institutional investor recently raised its position in TFF Pharmaceuticals stock. Westside Investment Management Inc. raised its stake in shares of TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) by 28.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,491 shares of the company’s stock after acquiring an additional 11,266 shares during the period. Westside Investment Management Inc. owned about 1.63% of TFF Pharmaceuticals worth $84,000 as of its most recent SEC filing. 15.25% of the stock is currently owned by institutional investors and hedge funds.

About TFF Pharmaceuticals

TFF Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions.